Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.6, 2005-06, pp. : 557-568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

By Giaginis Costas Margeli Alexandra Theocharis Stamatios

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1561-1572

Informa Healthcare

Access to resources Recommend Favorite

The Potential of Peroxisome Proliferator-Activated Receptor &ggr; (PPAR&ggr;) Ligands in the Treatment of Hematological Malignancies

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-09 ,pp. : 877-887

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F Choi Brian G Fuster Valentin Badimon Juan J

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis

By Malhotra Samir Bansal Dipika Shafiq Nusrat Pandhi Promila Kumar Bhushan

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1455-1461

Informa Healthcare

Access to resources Recommend Favorite

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer's Disease: Therapeutic Implications

By Jiang Qingguang

CNS Drugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite